Provided by Tiger Trade Technology Pte. Ltd.

Teva Pharmaceutical

37.34
+0.53001.44%
Post-market: 37.21-0.1287-0.34%19:53 EDT
Volume:4.30M
Turnover:160.85M
Market Cap:43.50B
PE:62.23
High:37.75
Open:36.79
Low:36.65
Close:36.81
52wk High:37.83
52wk Low:17.82
Shares:1.17B
Float Shares:1.09B
Volume Ratio:0.87
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.6000
EPS(LYR):1.21
ROE:9.69%
ROA:5.13%
PB:5.61
PE(LYR):30.86

Loading ...

Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 05, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 05, 2025

Major Issues Report

Form 8-K - Current report
Sep 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2025

Major Issues Report

Form 8-K - Current report
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 28, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Major Issues Report

Form 8-K - Current report
May 20, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
May 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]